| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-09 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |